XML 37 R56.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION PLANS (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2011
plan
Jun. 08, 2011
Dec. 31, 2011
Long-Term Incentive Plan
Options
Dec. 31, 2010
Long-Term Incentive Plan
Options
Y
Dec. 31, 2009
Long-Term Incentive Plan
Options
Y
Dec. 31, 2011
Equity Incentive Plan
Dec. 31, 2010
Equity Incentive Plan
Apr. 27, 2005
Equity Incentive Plan
Dec. 31, 2011
Equity Incentive Plan
Restricted Stock Awards (RSAs)
Dec. 31, 2010
Equity Incentive Plan
Restricted Stock Awards (RSAs)
Dec. 31, 2011
Equity Incentive Plan
Restricted Stock Awards (RSAs)
Outside directors
Dec. 31, 2011
Equity Incentive Plan
Restricted Stock Awards (RSAs)
Restricted stock awards to employees
Dec. 31, 2011
Equity Incentive Plan
Stock Appreciation Rights (SARs)
Dec. 31, 2009
Equity Incentive Plan
Stock Appreciation Rights (SARs)
Y
STOCK-BASED COMPENSATION PLANS                            
Number of stockholder-approved stock-based compensation plans 2                          
Stock-based Compensation                            
Options vested on anniversary date (as a percent)     25.00%                      
Vesting period 12 months   4 years                 48 months 48 months  
Expiration period of award (in years)     P10Y                   P10Y  
Summary of the awards made under the Long-Term Incentive Plan                            
Outstanding at the beginning of the period (in shares)     65,000 125,500                    
Exercised (in shares)     (65,000) (60,500)                    
Outstanding at the end of the period (in shares)       65,000                    
Weighted Average Exercise Price                            
Outstanding at the beginning of the period (in dollars per share)     $ 12.58 $ 12.75                    
Exercised (in dollars per share)     $ 12.58 $ 12.94                    
Outstanding at the end of the period (in dollars per share)       $ 12.58                    
Weighted Average Remaining Contractual Life                            
Weighted average remaining contractual life (in years)       1.01 1.6                  
Options Exercisable                            
Options exercisable at the beginning of the period (in shares)     65,000 125,500                    
Exercised (in shares)     (65,000) (60,500)                    
Options exercisable at the end of the period (in shares)       65,000                    
Shares authorized to be issued under the plan (in shares) 2,000,000 2,000,000           2,000,000            
Awards granted (in shares)                 85,426 77,956        
Awards cancelled (in shares)                   2,754        
Weighted average grant date fair value (in dollars per share)                 $ 17.44 $ 17.74        
Percentage of RSAs granted to outside directors expected to vest                     100.00%      
Assumptions utilized to determine the grant-date fair value                            
Expected dividend yield (as a percent)                           3.07%
Expected volatility (as a percent)                           22.10%
Risk-free interest rate (as a percent)                           2.84%
Expected holding period (in years)                           6.75
SARs outstanding and RSAs                            
Stock Appreciation Rights (SAR) outstanding                         361,356  
Exercisable (in shares)                         310,768  
Weighted average fair value of shares exercisable (in dollars per share)                         $ 3.70  
Compensation expense                            
Recorded compensation costs for the RSAs and SARs           $ 1,300 $ 1,077              
Unrecognized future compensation expense for the RSAs and SARs           $ 1,719